{"nct_id":"NCT03036488","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2017-03-07","start_date_type":"ACTUAL","primary_completion_date":"2025-10-14","primary_completion_date_type":"ESTIMATED","completion_date":"2025-10-14","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}